Startups
Investment Date: January 2022
Co-founded by the clinicians who co-developed the McLean Anxiety Mastery Program (MAMP) at McLean Hospital, the nationally recognized program for children and adolescents with moderate to severe anxiety and OCD, InStride Health is leading the way to provide desperately needed access to more effective treatment of severe anxiety and OCD. Driven by the belief that children and families living with mental health struggles deserve better access and outcomes, InStride is more than a continuum of care—it’s a pathway to a healthier life and hope for a more promising future.
Through this innovative care model, InStride is leading the way to provide desperately needed access to more effective treatment of anxiety and OCD. Driven by the belief that children and families living with mental health struggles deserve better access and outcomes so they never have to worry alone, InStride is more than a continuum of care—it’s a pathway to a healthier life and hope for a more promising future.
Co-founded by the clinicians who co-developed the McLean Anxiety Mastery Program (MAMP) at McLean Hospital, the nationally recognized program for children and adolescents with moderate to severe anxiety and OCD, InStride Health is leading the way to provide desperately needed access to more effective treatment of severe anxiety and OCD. Driven by the belief that children and families living with mental health struggles deserve better access and outcomes, InStride is more than a continuum of care—it’s a pathway to a healthier life and hope for a more promising future.
Through this innovative care model, InStride is leading the way to provide desperately needed access to more effective treatment of anxiety and OCD. Driven by the belief that children and families living with mental health struggles deserve better access and outcomes so they never have to worry alone, InStride is more than a continuum of care—it’s a pathway to a healthier life and hope for a more promising future.
Overview
Location
United States, Massachusetts, Boston
Total raised
$30M
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Hopelab | hopelab.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 24, 2024 | Startups addressing children's mental health needs that you should know | They include Brightline, Hazel Health, InStride Health, Mantra Health, and Mightier When it comes to mental health disorders in children, the stats are disheartening, with about 1 in 6 children aged 6 to 17 in the U.S. experiencing a mental... |
| Apr 4, 2024 | InStride Health: A Beacon of Hope for Pediatric Mental Health | InStride Health, a beacon of hope for pediatric mental health, recently secured $30M in Series B funding to expand access to high-quality, evidence-based care for children and adolescents struggling with anxiety and OCD. Led by CEO John Voi... |
| Apr 2, 2024 | Anthem Blue Cross and Blue Shield Expands Access to Specialty Mental Healthcare Treatment with Addition of InStride Health to Network | April 02, 2024 Read More News |
| Mar 29, 2024 | InStride Health Raises $30M in Series B Funding | InStride Health, a Boston, MA-based provider of specialty pediatric anxiety and OCD treatment, raised $30M in Series B funding. The round was led by General Catalyst with participation from previous investors .406 Ventures, Valtruis, Mass G... |
| Mar 27, 2024 | InStride Health Raises Oversubscribed $30 Million Series B to Expand Access to Best-In-Class Specialty Treatment for Pediatric Anxiety and OCD | BOSTON, Mass., – March 27, 2024 – InStride Health, an outpatient provider of specialty pediatric anxiety and OCD treatment, announced the closing of an oversubscribed $30M Series B funding round. General Catalyst led investors and was joine... |
| Mar 27, 2024 | InStride Health Secures $30M to Expand Access to Pediatric Mental Healthcare | What You Should Know: – InStride Health, a leader in outpatient treatment for childhood anxiety and OCD closes oversubscribed $30M Series B funding round led by General Catalyst with participation from existing investors .406 Ventures, Valt... |
| Mar 11, 2024 | Wellpoint Increases Access to Mental Healthcare for Children and Young Adults with Addition of InStride Health to Network | March 11, 2024 Read More News |
| Oct 7, 2022 | Pediatric mental health startup launches with $26M and a vow to scale Mass General’s proven care model | From left to right: InStride co-founders John Voith, Dr. Mona Potter, Jamie McEleney and Dr. Kathryn Boger Many families with children suffering from anxiety or obsessive-compulsive disorder feel like they have nowhere to turn for effective... |
| InStride Health | “Now offering services in New York, New Jersey, Massachusetts, Connecticut, New Hampshire, and Rhode Island.” |
Show more
Reviews 0
FAQ about InStride Health
How much funding has InStride Health raised?
InStride Health has raised $30M in total across 1 funding round.
Who has invested in InStride Health?
Parsers VC lists 2 investors of InStride Health, among them Hopelab.
What has the press written about InStride Health?
Parsers VC has collected 13 articles mentioning InStride Health, among them “Startups addressing children's mental health needs that you should know” (May 24, 2024) and “InStride Health: A Beacon of Hope for Pediatric Mental Health” (Apr 4, 2024).
Is InStride Health still active?
InStride Health is probably closed: its latest activity on Parsers VC dates from Feb 19, 2025.